Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yimuan Gong Capsule
- Development stage
- Phase 2
- Lead developer
- Yabao Pharmaceutical
- Administration
- Oral
01
Overview
Yimuan Gong Capsule is a Traditional Chinese Medicine (TCM) developed by Shanxi Yabao Pharmaceutical Group for the management of uterine bleeding following medical abortion. The formulation is designed to promote uterine involution, reduce the volume of vaginal bleeding, and shorten the duration of bleeding after the use of medical abortifacients. It typically incorporates herbal components known in TCM for their blood-activating and stasis-resolving properties, such as Motherwort (Leonurus japonicus). Clinical evaluation has included randomized, double-blind, phase 2 trials in China to assess its efficacy and safety compared to placebo in reducing post-abortion uterine bleeding.
- Brand names
- Yimuan Gong Capsule
- Other names
- Yimuan Gong Jiaonang
Beyond the preview
Go deeper on Yimuan Gong Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yimuan Gong Capsule.